ZA963154B - Arylalkyl pyridazinone - Google Patents

Arylalkyl pyridazinone

Info

Publication number
ZA963154B
ZA963154B ZA963154A ZA963154A ZA963154B ZA 963154 B ZA963154 B ZA 963154B ZA 963154 A ZA963154 A ZA 963154A ZA 963154 A ZA963154 A ZA 963154A ZA 963154 B ZA963154 B ZA 963154B
Authority
ZA
South Africa
Prior art keywords
pyridazinone
cooa
substd
halo
opt
Prior art date
Application number
ZA963154A
Other languages
English (en)
Inventor
Rochus Jonas
Michael Wolf
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA963154B publication Critical patent/ZA963154B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA963154A 1995-04-20 1996-04-19 Arylalkyl pyridazinone ZA963154B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19514568A DE19514568A1 (de) 1995-04-20 1995-04-20 Arylalkyl-pyridazinone

Publications (1)

Publication Number Publication Date
ZA963154B true ZA963154B (en) 1996-12-06

Family

ID=7759974

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963154A ZA963154B (en) 1995-04-20 1996-04-19 Arylalkyl pyridazinone

Country Status (21)

Country Link
US (2) US6399611B1 (cs)
EP (1) EP0738715B1 (cs)
JP (1) JP4005157B2 (cs)
KR (1) KR100428879B1 (cs)
CN (1) CN1159299C (cs)
AT (1) ATE231842T1 (cs)
AU (1) AU705025B2 (cs)
CA (1) CA2174472C (cs)
CZ (1) CZ291868B6 (cs)
DE (2) DE19514568A1 (cs)
DK (1) DK0738715T3 (cs)
ES (1) ES2191070T3 (cs)
HU (1) HU226198B1 (cs)
NO (1) NO307931B1 (cs)
PT (1) PT738715E (cs)
RU (1) RU2159236C2 (cs)
SI (1) SI0738715T1 (cs)
SK (1) SK284167B6 (cs)
TW (1) TW475927B (cs)
UA (1) UA43853C2 (cs)
ZA (1) ZA963154B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
JP4017214B2 (ja) 1996-06-11 2007-12-05 興和創薬株式会社 ５−フェニル−３−ピリダジノン誘導体
US6265402B1 (en) * 1996-08-27 2001-07-24 Nikken Chemicals Co., Ltd. Use of 2-phenylmorpholin-5-one derivatives
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
BR9914091A (pt) * 1998-10-06 2001-11-27 Dainippon Pharmaceutical Co Derivados de piridina 2,3-di-substituìda, processopara preparação dos mesmos, composições dedroga contendo os mesmos e intermediários paraa preparação
DE19850701A1 (de) 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
RU2279428C2 (ru) * 2000-09-18 2006-07-10 Эйсай Ко., Лтд. Производные пиридазинона и триазинона и их применение в качестве фармацевтических препаратов
DE10064997A1 (de) * 2000-12-23 2002-06-27 Merck Patent Gmbh Benzoylpyridazine
HUP0303181A2 (hu) * 2001-02-12 2004-01-28 Merck Patent Gmbh. 4-Foszfodiészteráz típusú inhibitorok alkalmazása miokardiális betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
CN1537018A (zh) 2001-05-23 2004-10-13 田边制药株式会社 一种用于软骨疾病再生治疗的组合物
KR20040007596A (ko) * 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 골절 치료 촉진용 조성물
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
CN1578665A (zh) * 2001-10-31 2005-02-09 默克专利股份公司 4型磷酸二脂酶抑制剂及其应用
ES2195785B1 (es) * 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US7074959B2 (en) * 2002-08-01 2006-07-11 New Mexico Highlands University Methods and systems for remediating hydrazine-contaminated equipment and/or surfaces
ES2211344B1 (es) * 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
WO2005075456A1 (en) * 2004-02-04 2005-08-18 Altana Pharma Ag 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
US20080227790A1 (en) * 2004-02-04 2008-09-18 Altana Pharma Ag Pyridazinone Derivatives and their Use as Pde4 Inhibitors
ES2251867B1 (es) * 2004-06-21 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
CA2672601A1 (en) * 2006-12-14 2008-06-19 Astellas Pharma Inc. Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
US8466198B2 (en) * 2008-09-02 2013-06-18 Bruce Kneller Compositions comprising creatine salts and methods of use thereof
US20110052729A1 (en) * 2009-08-26 2011-03-03 Golini Jeffrey M Pharmaceutical or nutraceutical composition
AU2017232906B2 (en) 2016-03-16 2022-03-31 H. Lee Moffitt Cancer Center & Research Institute, Inc. Small molecules against cereblon to enhance effector T cell function
MX2021000295A (es) 2018-07-11 2021-03-31 H Lee Moffitt Cancer Ct & Res Compuestos inmunomoduladores dimericos contra mecanismos basados en cereblon.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604863A (cs) * 1967-11-22 1972-04-17
US3975388A (en) * 1971-02-22 1976-08-17 Bdh Pharmaceuticals Limited Pyridazinones
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
SU1313346A3 (ru) * 1981-09-17 1987-05-23 Варнер-Ламберт,Компани (Фирма) Способ получени замещенных 6-арил-3(2 @ )-пиридазинонов
US4734415A (en) * 1982-08-13 1988-03-29 Warner-Lambert Company Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones
PT78566B (de) * 1983-05-11 1986-07-17 Byk Gulden Lomberg Chem Fab Pyridazinone ihre herstellung und verwendung pyridazinone enthaltende arzneimittel
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類
DE3704879A1 (de) * 1987-02-17 1988-08-25 Merck Patent Gmbh Pyridazinonderivate
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
US5175161A (en) * 1989-04-06 1992-12-29 Sankyo Company, Limited Occular hypotensive agents
KR910004574A (ko) * 1989-08-10 1991-03-28 글락소 인크 강심 작용 및 베타 차단 작용을 갖는 피리다지논류
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
JP2806192B2 (ja) * 1992-11-02 1998-09-30 日本曹達株式会社 血小板凝集抑制剤
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone

Also Published As

Publication number Publication date
US6531473B2 (en) 2003-03-11
KR960037662A (ko) 1996-11-19
HU9601034D0 (en) 1996-06-28
ES2191070T3 (es) 2003-09-01
UA43853C2 (uk) 2002-01-15
NO307931B1 (no) 2000-06-19
DE59610081D1 (de) 2003-03-06
DE19514568A1 (de) 1996-10-24
ATE231842T1 (de) 2003-02-15
CA2174472C (en) 2008-10-21
CN1159299C (zh) 2004-07-28
CZ291868B6 (cs) 2003-06-18
HU226198B1 (en) 2008-06-30
AU705025B2 (en) 1999-05-13
EP0738715A3 (de) 1998-06-17
RU2159236C2 (ru) 2000-11-20
NO961578D0 (no) 1996-04-19
US6399611B1 (en) 2002-06-04
CN1142493A (zh) 1997-02-12
SK48796A3 (en) 1997-02-05
EP0738715B1 (de) 2003-01-29
SI0738715T1 (en) 2003-10-31
CZ113296A3 (en) 1996-11-13
NO961578L (no) 1996-10-21
CA2174472A1 (en) 1996-10-21
HUP9601034A3 (en) 1999-03-01
AU5071196A (en) 1996-10-31
HUP9601034A2 (en) 1996-12-30
JP4005157B2 (ja) 2007-11-07
KR100428879B1 (ko) 2004-07-15
TW475927B (en) 2002-02-11
US20020111356A1 (en) 2002-08-15
PT738715E (pt) 2003-06-30
SK284167B6 (sk) 2004-10-05
DK0738715T3 (da) 2003-05-26
JPH08291145A (ja) 1996-11-05
EP0738715A2 (de) 1996-10-23

Similar Documents

Publication Publication Date Title
ZA963154B (en) Arylalkyl pyridazinone
PL311194A1 (en) New derivatives of oxazolidinone acid and method of their production as well as pharmaceutical compound together with method of its production
AU4211196A (en) Arylalkyl-thiadiazinones
HU9600914D0 (en) 4-indolylpiperazinyl derivatives
IL120101A0 (en) Urokinase receptor ligands
ZA958909B (en) Alkyl-5-methylsulfonyl-benzoylguanidin-derivate
GR3035481T3 (en) Alkenyl-benzoylguanidines
ZA966832B (en) Substituted 4H-pyrans.
PH31390A (en) Cyclohexadiene derivatives.
HUP9903260A2 (hu) Antibiotikus hatású 2,4-diamino-pirimidin-származékok, előállításuk és alkalmazások
GR3035097T3 (en) Acyl substituted aminopyrans with a modulating effect on calcium channels
TW328903B (en) Substituted quinoline herbicide intermediates and process
RU98118491A (ru) Производные изоксазола